<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>33(1)</volume><submitter>Hong M</submitter><pubmed_abstract>&lt;h4>Objectives&lt;/h4>Early detection of developmental issues in infants and necessary intervention are important. To identify the comorbid conditions, a comprehensive evaluation is required. The study's objectives were to 1) generate scale items by identifying and eliciting concepts relevant to young children (12-71 months) with developmental delays, 2) develop a comprehensive screening tool for developmental delay and comorbid conditions, and 3) assess the tool's validity and cut-off.&lt;h4>Methods&lt;/h4>Multidisciplinary experts devised the "Infant Comprehensive Evaluation for Neurodevelopmental Delay (ICEND)," an assessment method that comes in two versions depending on the age of the child: 12-36 months and 37-71 months, through monthly seminars and focused group interviews. The ICEND is comp</pubmed_abstract><journal>Soa--ch'ongsonyon chongsin uihak = Journal of child &amp; adolescent psychiatry</journal><pagination>16-23</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8733413</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Preliminary Report of Validity for the Infant Comprehensive Evaluation for Neurodevelopmental Delay, a Newly Developed Inventory for Children Aged 12 to 71 Months.</pubmed_title><pmcid>PMC8733413</pmcid><pubmed_authors>Hong M</pubmed_authors><pubmed_authors>Bahn GH</pubmed_authors><pubmed_authors>Lee KS</pubmed_authors><pubmed_authors>Shin YW</pubmed_authors><pubmed_authors>Lee SY</pubmed_authors><pubmed_authors>Kang JY</pubmed_authors><pubmed_authors>Moon DS</pubmed_authors><pubmed_authors>Cho YI</pubmed_authors><pubmed_authors>Cho S</pubmed_authors><pubmed_authors>Hwangbo R</pubmed_authors><pubmed_authors>Park JA</pubmed_authors></additional><is_claimable>false</is_claimable><name>Preliminary Report of Validity for the Infant Comprehensive Evaluation for Neurodevelopmental Delay, a Newly Developed Inventory for Children Aged 12 to 71 Months.</name><description>&lt;h4>Objectives&lt;/h4>Early detection of developmental issues in infants and necessary intervention are important. To identify the comorbid conditions, a comprehensive evaluation is required. The study's objectives were to 1) generate scale items by identifying and eliciting concepts relevant to young children (12-71 months) with developmental delays, 2) develop a comprehensive screening tool for developmental delay and comorbid conditions, and 3) assess the tool's validity and cut-off.&lt;h4>Methods&lt;/h4>Multidisciplinary experts devised the "Infant Comprehensive Evaluation for Neurodevelopmental Delay (ICEND)," an assessment method that comes in two versions depending on the age of the child: 12-36 months and 37-71 months, through monthly seminars and focused group interviews. The ICEND is comp</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jan</publication><modification>2025-04-04T20:31:55.335Z</modification><creation>2022-02-11T15:20:30.483Z</creation></dates><accession>S-EPMC8733413</accession><cross_references><pubmed>35035238</pubmed><doi>10.5765/jkacap.210033</doi></cross_references></HashMap>